Gene enrichment results carried out using the Gene Ontology (GO) enrichment analysis web-based bioinformatics tool WEB-based GEne SeT AnaLysis Toolkit (WebGestalt).

<p>Gene enrichment results carried out using the Gene Ontology (GO) enrichment analysis web-based bioinformatics tool WEB-based GEne SeT AnaLysis Toolkit (WebGestalt).</p

DNA methylation differences at specific loci between smoking and non-smoking discordant twin pairs.

<p>DNA methylation differences at specific loci between smoking and non-smoking discordant twin pairs.</p

Correlation between methylation levels and smoking intensity (expressed as pack-years) for 2q37.1, <i>EPB41L1</i> and <i>MYO1G</i> loci.

<p>Correlation between methylation levels and smoking intensity (expressed as pack-years) for 2q37.1, <i>EPB41L1</i> and <i>MYO1G</i> loci.</p

HRs and 95% CIs of breast cancer by HER2 status in relation to quartiles of B vitamin intake in ORDET women.

<p>* Adjusted for height, waist-hip-ratio, age at menarche, menopausal status, oral contraceptive use, parity, education, family history of breast cancer, energy intake, and alcohol intake.</p><p>** Tests for linear trend were calculated by assigning an ordinal number to each quartile.</p><p># HR of developing breast cancer per 1 SD increase in vitamin intake.</p><p>## HER2+ vs. HER2-.</p><p>HRs and 95% CIs of breast cancer by HER2 status in relation to quartiles of B vitamin intake in ORDET women.</p

HRs (95% CIs) of breast cancer by ER plus PR status in relation to quartiles of B vitamin intake in ORDET women.

<p>* Adjusted for height, waist-hip-ratio, age at menarche, menopausal status, oral contraceptive use, parity, education, family history of breast cancer, energy intake, and alcohol intake.</p><p>** Tests for linear trend were calculated by assigning an ordinal number to each quartile.</p><p># HR of developing breast cancer per 1 SD increase in vitamin intake.</p><p>## ER+PR+ vs. ER-PR-</p><p>HRs (95% CIs) of breast cancer by ER plus PR status in relation to quartiles of B vitamin intake in ORDET women.</p

HRs (95% CIs) of breast cancer in relation to quartiles of B vitamin intake in ORDET women.

<p>* Adjusted by energy intake.</p><p>** Adjusted by height, waist hip ratio, age at menarche, menopausal status, oral contraceptive use, parity, education, family history of breast cancer, energy intake and alcohol intake.</p><p># Tests for linear trend were calculated by assigning an ordinal number to each quartile.</p><p>## HR of developing breast cancer per 1 SD increase in vitamin intake</p><p>HRs (95% CIs) of breast cancer in relation to quartiles of B vitamin intake in ORDET women.</p

Baseline distribution of nutrients and factors influencing breast cancer risk by disease status in ORDET women.

<p>* SD = standard deviation</p><p>Baseline distribution of nutrients and factors influencing breast cancer risk by disease status in ORDET women.</p

Wilcoxon sum rank test on leukocyte telomere length presented t/s ratio normalized and cardiovascular risk factors of cases (n = 199).

<p>Data are presented as means and standard deviation. LTL, leukocyte telomere length; CAD, coronary artery disease.</p

A, Event free survival from major cardiovascular events in patients on basis of leukocyte telomere length at enrollment measured as t/s.

<p>B, Event free survival from major cardiovascular events in patients on basis of leukocyte telomere length at enrollment measured as t/s normalized.</p

Wilcoxon sum rank test on leukocyte telomere length presented t/s ratio normalized and cardiovascular risk factors of controls (n = 190).

<p>Data are presented as means and standard deviation. LTL, leukocyte telomere length; CAD, coronary artery disease.</p